We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+16.69%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$361M
AUM Growth
+$61M
Cap. Flow
+$17.1M
Cap. Flow %
4.75%
Top 10 Hldgs %
25.92%
Holding
346
New
32
Increased
163
Reduced
43
Closed
36

Top Sells

Rank Stock Value
1
CMA
Comerica
CMA
+$5.93M
2
MSFT icon
Microsoft
MSFT
+$5.32M
3
EQR icon
Equity Residential
EQR
+$5.24M
4
BKR icon
Baker Hughes
BKR
+$4.61M
5
SEE
Sealed Air
SEE
+$618K

Sector Composition

Rank Sector Weight
1 Healthcare 20.18%
2 Consumer Staples 15.06%
3 Energy 14.25%
4 Financials 13.67%
5 Industrials 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCK icon
1
McKesson
MCK
$104B
$11.9M 3.29%
31,634
-407
-1% -$152K
SLB icon
2
SLB Ltd
SLB
$74.4B
$10.7M 2.96%
199,927
-487
-0.2% -$24.3K
MPC icon
3
Marathon Petroleum
MPC
$90.2B
$10.5M 2.92%
90,364
-1,362
-1% -$155K
HAL icon
4
Halliburton
HAL
$26.2B
$10.3M 2.86%
262,565
-2,583
-1% -$91.4K
UNH icon
5
UnitedHealth
UNH
$391B
$9.17M 2.54%
17,297
+243
+1% +$129K
LLY icon
6
Eli Lilly
LLY
$1.09T
$8.8M 2.44%
24,041
+1,245
+5% +$441K
MRK icon
7
Merck
MRK
$325B
$8.72M 2.42%
78,632
+4,511
+6% +$461K
MTD icon
8
Mettler-Toledo International
MTD
$28.1B
$8.13M 2.25%
5,625
+116
+2% +$155K
GIS icon
9
General Mills
GIS
$20.1B
$7.69M 2.13%
91,669
+1,872
+2% +$152K
ULTA icon
10
Ulta Beauty
ULTA
$21.4B
$7.59M 2.1%
16,175
+860
+6% +$371K
CAG icon
11
Conagra Brands
CAG
$7.39B
$7.55M 2.09%
194,994
+5,688
+3% +$206K
CAH icon
12
Cardinal Health
CAH
$54.7B
$7.36M 2.04%
95,781
+3,170
+3% +$241K
COP icon
13
ConocoPhillips
COP
$139B
$7.22M 2%
61,228
+748
+1% +$90.9K
TRV icon
14
Travelers Companies
TRV
$82.8B
$7.21M 2%
38,447
+752
+2% +$135K
RTX icon
15
RTX Corp
RTX
$294B
$7.02M 1.95%
69,553
+2,992
+4% +$281K
AFL icon
16
Aflac
AFL
$65.6B
$6.95M 1.93%
96,576
+1,922
+2% +$129K
ELV icon
17
Elevance Health
ELV
$83.5B
$6.83M 1.89%
13,309
+267
+2% +$136K
WLK icon
18
Westlake Corp
WLK
$9.27B
$6.74M 1.87%
65,760
+776
+1% +$78.2K
MRSH
19
Marsh
MRSH
$91.1B
$6.67M 1.85%
40,337
+37,108
+1,149% +$6.07M
AON icon
20
Aon
AON
$81B
$6.67M 1.85%
22,220
+955
+4% +$279K
PG icon
21
Procter & Gamble
PG
$348B
$6.64M 1.84%
43,790
+1,090
+3% +$153K
MDLZ icon
22
Mondelez International
MDLZ
$80B
$6.57M 1.82%
98,587
+3,122
+3% +$197K
UBS icon
23
UBS Group
UBS
$171B
$6.52M 1.81%
349,237
+8,043
+2% +$137K
BDX icon
24
Becton Dickinson
BDX
$45.6B
$6.5M 1.8%
25,579
+837
+3% +$198K
ETR icon
25
Entergy
ETR
$52.9B
$6.5M 1.8%
115,506
+2,796
+2% +$153K

Similar funds

Contravisory Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Contravisory Investment Management held 346 positions worth $361M, up 20% from $300M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Contravisory Investment Management deployed $17.1M of net new capital in Q4 2022, opening 32 new positions and adding to 163 existing holdings. Its largest new stake was PepsiCo: 34,763 shares worth $6.28M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 20% a quarter earlier, followed by Consumer Staples and Energy.

On the sell side, the largest reduction was Comerica, an estimated $5.93M trimmed.

  • Contravisory Investment Management's largest Q4 2022 buy was PepsiCo: 34,763 shares worth $6.28M.
  • Contravisory Investment Management added most to Dollar General in Q4 2022, an estimated $6.18M increase.
  • Contravisory Investment Management's biggest Q4 2022 reduction was Comerica, cutting an estimated $5.93M.
  • Contravisory Investment Management fully exited Baker Hughes in Q4 2022, selling an estimated $4.61M.
  • Contravisory Investment Management's ten largest holdings make up 26% of its $361M portfolio in Q4 2022.
  • Contravisory Investment Management opened 32 new positions and closed 36 in Q4 2022.
  • Contravisory Investment Management's portfolio value rose 20% quarter-over-quarter to $361M.

Based on Contravisory Investment Management's 13F filing for Q4 2022, filed 13 Jan 2023.